Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
---|
09/28/2005 | CN1675169A Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acid |
09/28/2005 | CN1673212A Interconnected medicine precursor of gabapentin and pregabalin and its medicinal use |
09/27/2005 | US6949677 Carbocyclic carboxy, oxo amines such as N-Isopropyl-3-oxo-N-[4-(phenylamino)phenyl]butyramide, used as fuel additives or drying promoters for polymers |
09/27/2005 | US6949663 Multilayer; anticoagulant |
09/27/2005 | US6949658 Water solvent is substituted with a linear, branched, or cyclic alcohol having 3 or more carbon atoms; the acid is preferentially precipitated from the alcohol; addition of a base enables purification of the alpha amino amide |
09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
09/27/2005 | US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders |
09/27/2005 | US6949516 Oligopeptides used as antiapoptosis agents |
09/27/2005 | CA2120942C Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation |
09/22/2005 | WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
09/22/2005 | WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
09/22/2005 | WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors |
09/22/2005 | WO2005004802A3 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
09/22/2005 | US20050209465 By reacting with substituted acetylenes in the presence of a phosphine ligand and a base (K2CO3); used to make drugs |
09/22/2005 | US20050209327 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines |
09/22/2005 | US20050208015 Glycerol derivative |
09/22/2005 | CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
09/22/2005 | CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors |
09/21/2005 | EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use |
09/21/2005 | EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates |
09/21/2005 | EP1577292A1 Phenylaminoethanol derivatives as beta2 receptor agonists |
09/21/2005 | EP1577291A1 Phenylethanolamine derivatives as beta-2 agonists |
09/21/2005 | EP1577289A1 Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders |
09/21/2005 | EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions |
09/21/2005 | EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
09/21/2005 | CN1671654A Gelling agents |
09/21/2005 | CN1671639A Novel biphenyl and biphenyl-like cannabinoids |
09/21/2005 | CN1219751C Industrial production of benzofloxamide |
09/20/2005 | US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
09/20/2005 | US6946453 Such as 7-azido-6-demethyl-6-deoxy-4-dedimethylamino tetracycline; for treatment of arthritis, bone disorders (osteoporosis), and emphysema |
09/15/2005 | WO2005085188A2 Compounds and methods for anti-tumor therapy |
09/15/2005 | WO2005084658A1 Derivatives of actarit and their therapeutic use |
09/15/2005 | WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
09/15/2005 | US20050203313 Production process of aminomethyl group-containing benzamide compound |
09/15/2005 | US20050203170 Chalcones substitued with amine or amino acid-derived amide, specifically (S)-2-amino-3-hydroxypropanoic acid (2-methoxy-5-[2-methyl-3-oxo-3-(3,4,5-trimethoxyphenyl)propenyl]phenyl)amide hydrochloride; use inhibiting tubulin polymerization; antitumor agents |
09/15/2005 | US20050203108 Glucagon antagonists/inverse agonists |
09/14/2005 | EP1574495A1 Adamantane derivatives |
09/14/2005 | EP1574494A1 Adamantane derivative |
09/14/2005 | EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS |
09/14/2005 | EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
09/14/2005 | CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
09/13/2005 | US6943269 Contrast media for angiography |
09/13/2005 | US6943191 dihydroxy or diketoaromatic compounds; protein kinase inhibitors; antiproliferative activity |
09/09/2005 | WO2005082860A1 Tetracyclines and their use as calpain inhibitors |
09/08/2005 | US20050197401 Growth factor-binding compounds and methods of use |
09/07/2005 | EP1569896A1 Tetrahydro-naphthalene derivatives |
09/07/2005 | EP1569893A2 Amino substituted hydroxyphenyl benzophenone derivatives |
09/07/2005 | EP1192132B1 Serine protease inhibitors |
09/07/2005 | EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
09/06/2005 | US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine, |
09/06/2005 | US6939889 Quarternary ammonium compounds |
09/06/2005 | US6939880 Compounds with growth hormone releasing properties |
09/06/2005 | CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them |
09/06/2005 | CA2067690C Amino acid derivatives |
09/01/2005 | WO2005080316A2 Modulators of cannabinoid receptors |
09/01/2005 | WO2005079541A2 Terephthalamide peptidomimetic compounds and methods |
09/01/2005 | WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
09/01/2005 | US20050192465 Process for the preparation of iopamidol |
09/01/2005 | US20050192354 Such as N-alpha-(cyanoacetyl)-L-histidine; dipeptides |
09/01/2005 | US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections |
09/01/2005 | US20050192231 Treating hepatitis with a cytoprotective agents such as benzyloxycarbonyl-valine-aspartic acid(methyl ester)-methyl fluoride or having leucine and isoleucine as replacements for valine; caspase enzyme inhibitors; fas antigen suppressors; neuroprotective agents; antiischemic agents; organ transplants |
09/01/2005 | CA2556940A1 Modulator |
09/01/2005 | CA2556447A1 Terephthalamide peptidomimetic compounds and methods |
08/31/2005 | EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses |
08/31/2005 | EP1568683A2 Secondary, N-alkylaminated para-phenylenediamines, compositions for dyeing keratinic fibres containing them, processes using this compositions and uses thereof |
08/31/2005 | EP1163212B1 Amide derivatives |
08/31/2005 | CN1660783A Fluorescence compound of polyamide and its application in recognizing hypersensitive light signal of positive ions |
08/30/2005 | US6936736 Vision defects; Parkinson's disease; Alzheimer's disease |
08/25/2005 | WO2005077945A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
08/25/2005 | WO2005077884A2 Hydroaminomethylation of olefins |
08/25/2005 | WO2005077122A2 Compounds and compositions as lxr modulators |
08/25/2005 | WO2005061437A3 Isopeptide gap junction modulators |
08/25/2005 | US20050187284 Integrin receptor inhibitors |
08/25/2005 | US20050187198 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
08/25/2005 | US20050187167 Polyene polyketides, processes for their production and their use as a pharmaceutical |
08/25/2005 | US20050186176 Compounds and compositions for delivering active agents |
08/25/2005 | CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
08/25/2005 | CA2553442A1 Compounds and compositions as lxr modulators |
08/24/2005 | EP1566376A1 Preparation of amino acid amides |
08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
08/24/2005 | CN1659136A Novel sodium channel blockers |
08/24/2005 | CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
08/24/2005 | CN1659134A Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom |
08/23/2005 | US6933352 Amphiphilic compounds having a dendritic branch structure |
08/23/2005 | US6933314 Integrin receptor inhibitors |
08/18/2005 | WO2005075455A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
08/18/2005 | US20050182262 Reacting an amino acid or acid salt with a halogenating agent (thionyl chloride, phosphorous pentachloride or oxalyl chloride) , to form an intermediate, reacting the intermediate with ammonia; amidation; chemical intermediate to form Levetiracetam |
08/18/2005 | US20050182040 Benzamide derivatives |
08/18/2005 | CA2720312A1 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
08/18/2005 | CA2497062A1 Preparation of amino acid amides |
08/17/2005 | EP1562575A1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy |
08/17/2005 | CN1656065A Ligand as the RAR receptor inhibitor |
08/17/2005 | CN1656058A Amide derivatives as inhibitors of the enzymatic activity of renin |
08/17/2005 | CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
08/17/2005 | CN1656056A Production process of aminomethyl group-containing benzamide compound |
08/17/2005 | CN1655774A Bis-aromatic alkanols |
08/17/2005 | CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
08/17/2005 | CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives |